(Q51969727)
Statements
Efalizumab therapy for atopic dermatitis causes marked increases in circulating effector memory CD4+ T cells that express cutaneous lymphocyte antigen. (English)
1 reference
Andrew Blauvelt
1 reference
Erin G Harper
1 reference
Eric L Simpson
1 reference
Rodd H Takiguchi
1 reference
Miranda D Boyd
1 reference
Stephen E Kurtz
1 reference
Antony C Bakke
1 reference
15 November 2007
1 reference
128
1 reference
5
1 reference
1173-1181
1 reference
Identifiers
1 reference